252 related articles for article (PubMed ID: 15869918)
21. Reciprocal antagonism coordinates C-type natriuretic peptide and mitogen-signaling pathways in fibroblasts.
Chrisman TD; Garbers DL
J Biol Chem; 1999 Feb; 274(7):4293-9. PubMed ID: 9933630
[TBL] [Abstract][Full Text] [Related]
22. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
23. Phosphate stimulates matrix Gla protein expression in chondrocytes through the extracellular signal regulated kinase signaling pathway.
Julien M; Magne D; Masson M; Rolli-Derkinderen M; Chassande O; Cario-Toumaniantz C; Cherel Y; Weiss P; Guicheux J
Endocrinology; 2007 Feb; 148(2):530-7. PubMed ID: 17068135
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway.
Murakami S; Kan M; McKeehan WL; de Crombrugghe B
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1113-8. PubMed ID: 10655493
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: interference between CNP and endothelin-1 signaling pathways.
Tokudome T; Horio T; Soeki T; Mori K; Kishimoto I; Suga S; Yoshihara F; Kawano Y; Kohno M; Kangawa K
Endocrinology; 2004 May; 145(5):2131-40. PubMed ID: 14749356
[TBL] [Abstract][Full Text] [Related]
26. C-Type Natriuretic Peptide Dampens Fibroblast Growth Factor-23 Expression Through MAPK Signaling Pathway in Human Mesangial Cells.
Wu YF; Zhang DD; Liu SY; Luo HH; Jiang GM; Xu Y; Wu Y; Wang JJ; Liu FF; Samadli S; Wei W; Hu B; Hu P
J Interferon Cytokine Res; 2018 Nov; 38(11):500-509. PubMed ID: 30335543
[TBL] [Abstract][Full Text] [Related]
27. Is C-type natriuretic peptide regulated by a feedback loop? A study on systemic and local autoregulatory effect.
Ueda Y; Hirota K; Yamauchi I; Hakata T; Yamashita T; Fujii T; Yasoda A; Inagaki N
PLoS One; 2020; 15(10):e0240023. PubMed ID: 33002060
[TBL] [Abstract][Full Text] [Related]
28. Sildenafil Potentiates a cGMP-Dependent Pathway to Promote Melanoma Growth.
Dhayade S; Kaesler S; Sinnberg T; Dobrowinski H; Peters S; Naumann U; Liu H; Hunger RE; Thunemann M; Biedermann T; Schittek B; Simon HU; Feil S; Feil R
Cell Rep; 2016 Mar; 14(11):2599-610. PubMed ID: 26971999
[TBL] [Abstract][Full Text] [Related]
29. Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts.
Horio T; Tokudome T; Maki T; Yoshihara F; Suga S; Nishikimi T; Kojima M; Kawano Y; Kangawa K
Endocrinology; 2003 Jun; 144(6):2279-84. PubMed ID: 12746286
[TBL] [Abstract][Full Text] [Related]
30. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
[TBL] [Abstract][Full Text] [Related]
31. Activation of mitogen-activated protein kinase pathway by keratinocyte growth factor or fibroblast growth factor-10 promotes cell proliferation in human endometrial carcinoma cells.
Taniguchi F; Harada T; Sakamoto Y; Yamauchi N; Yoshida S; Iwabe T; Terakawa N
J Clin Endocrinol Metab; 2003 Feb; 88(2):773-80. PubMed ID: 12574212
[TBL] [Abstract][Full Text] [Related]
32. Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure.
Špiranec K; Chen W; Werner F; Nikolaev VO; Naruke T; Koch F; Werner A; Eder-Negrin P; Diéguez-Hurtado R; Adams RH; Baba HA; Schmidt H; Schuh K; Skryabin BV; Movahedi K; Schweda F; Kuhn M
Circulation; 2018 Jul; 138(5):494-508. PubMed ID: 29626067
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Lorget F; Kaci N; Peng J; Benoist-Lasselin C; Mugniery E; Oppeneer T; Wendt DJ; Bell SM; Bullens S; Bunting S; Tsuruda LS; O'Neill CA; Di Rocco F; Munnich A; Legeai-Mallet L
Am J Hum Genet; 2012 Dec; 91(6):1108-14. PubMed ID: 23200862
[TBL] [Abstract][Full Text] [Related]
34. Sequential exposure to fibroblast growth factors (FGF) 2, 9 and 18 enhances hMSC chondrogenic differentiation.
Correa D; Somoza RA; Lin P; Greenberg S; Rom E; Duesler L; Welter JF; Yayon A; Caplan AI
Osteoarthritis Cartilage; 2015 Mar; 23(3):443-53. PubMed ID: 25464167
[TBL] [Abstract][Full Text] [Related]
35. C-type natriuretic peptide promotes adipogenic differentiation of goat adipose-derived stem cells via cGMP/PKG/ p38 MAPK signal pathway.
Ai X; Hou X; Guo T
In Vitro Cell Dev Biol Anim; 2021 Oct; 57(9):865-877. PubMed ID: 34786662
[TBL] [Abstract][Full Text] [Related]
36. C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways.
Agoston H; Khan S; James CG; Gillespie JR; Serra R; Stanton LA; Beier F
BMC Dev Biol; 2007 Mar; 7():18. PubMed ID: 17374144
[TBL] [Abstract][Full Text] [Related]
37. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
38. C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system.
Suda M; Tanaka K; Fukushima M; Natsui K; Yasoda A; Komatsu Y; Ogawa Y; Itoh H; Nakao K
Biochem Biophys Res Commun; 1996 Jun; 223(1):1-6. PubMed ID: 8660352
[TBL] [Abstract][Full Text] [Related]
39. Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B).
Abbey-Hosch SE; Cody AN; Potter LR
Hypertension; 2004 May; 43(5):1103-9. PubMed ID: 15037564
[TBL] [Abstract][Full Text] [Related]
40. Alteration of cGMP metabolism during chondrogenic differentiation of chondroprogenitor-like EC cells, ATDC5.
Fujishige K; Kotera J; Yanaka N; Akatsuka H; Omori K
Biochim Biophys Acta; 1999 Dec; 1452(3):219-27. PubMed ID: 10590311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
